– Infinity Previously Announced Definitive Merger Agreement with MEI Pharma to Advance Three Promising Clinical Oncology Candidates – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. ...
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...
Total loans were $223.7 million as of March 31, 2026, compared to $229.8 million for the fourth quarter of 2025, a decrease of $6.1 million, or (2.6%). When compared to the first quarter of 2025, ...
– Infinity Previously Announced Definitive Merger Agreement with MEI Pharma to Advance Three Promising Clinical Oncology Candidates – Research and development expenses for 2022 were $32.4 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results